Photo from wikipedia
Immune checkpoint inhibitors have revolutionized the treatment of cancer and are now omnipresent. However, immune-related adverse events can present with varying phenotypes and timing, which can pose diagnostic and therapeutic… Click to show full abstract
Immune checkpoint inhibitors have revolutionized the treatment of cancer and are now omnipresent. However, immune-related adverse events can present with varying phenotypes and timing, which can pose diagnostic and therapeutic challenges for the treating oncologist as well as subspecialty consultants. Biopsies of affected organs may provide insight into biologic mechanisms as well as potentially guide management in certain circumstances.
Keywords:
immune checkpoint;
role tissue;
biopsy management;
tissue biopsy;
checkpoint
Journal Title: Journal of the National Comprehensive Cancer Network : JNCCN
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the National Comprehensive Cancer Network : JNCCN
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!